跳至主要内容
临床试验/NCT01858675
NCT01858675已完成不适用

Predictive Value of Biomarkers on Volemia, Extra and Intra Vascular Varation and Hydroelectrolytic Disorders in Different ICU Patients

ThermoFisher Scientific Brahms Biomarkers France2 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2012年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
66
试验地点
2
主要终点
Predictive value of biomarkers changes in Volemia variation

研究概览

简要总结

The purpose of this study is to determine whether the Biomarkers (pro adrenomedullin (MR proADM), pro arginin vasopressin (CT proAVP), pro atrial natriuretic peptid (MR proANP), Pro Endothelin) changes at Day 2, Day 5 and Day 7 of ICU admission are correlated with Intravascular volume assessed by Cr 51 on red blood cells (Day 2 and Day 7) and by I 125 on albumine Day 7. The correlation of these Biomarkers are also evaluted with other markers such as erythropoietin and catecholamines. 80 ICU patients are included.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 20 Cerebral Hemorrhage
  • 20 Head Injury
  • 20 post surgery non traumatic non neuro
  • 20 Polytrauma patients

排除标准

  • Heart failure NYHA III or IV
  • Renal insufficiency creatinin clearance < 30 ml/mn
  • age < 18 Y
  • Pregnancy

结局指标

主要结局

Predictive value of biomarkers changes in Volemia variation

时间窗: at Day 2, Day 5 and Day 7 of ICU admission

Correlation with total blood volume(assessed by Cr 51) and biomarkers(Mr proADM, Mr proANP, CT proAVP and proendothelin)changes

次要结局

  • Predictive value of biomarkers changes with efficient volemia, fluid managements and other Markers such erythropoietin(at Day 2, Day 5 and Day 7 of ICU admission)
  • Predictive value of Biomarkers with APACHE II and SOFA score and Prognosis at ICU discharge(at Day 2 , Day 5 and Day 7 of ICU admission and at discharge)

研究者

发起方
ThermoFisher Scientific Brahms Biomarkers France
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Biomarkers Correlation With Volemia | 临床试验